180 related articles for article (PubMed ID: 35921533)
1. Genome-wide CRISPR screens identify CD48 defining susceptibility to NK cytotoxicity in peripheral T-cell lymphomas.
Chiba M; Shimono J; Ishio T; Takei N; Kasahara K; Ogasawara R; Ara T; Goto H; Izumiyama K; Otsuguro S; Perera LP; Hasegawa H; Maeda M; Hashino S; Maenaka K; Teshima T; Waldmann TA; Yang Y; Nakagawa M
Blood; 2022 Nov; 140(18):1951-1963. PubMed ID: 35921533
[TBL] [Abstract][Full Text] [Related]
2. Whole-genome CRISPR screening identifies molecular mechanisms of PD-L1 expression in adult T-cell leukemia/lymphoma.
Chiba M; Shimono J; Suto K; Ishio T; Endo T; Goto H; Hasegawa H; Maeda M; Teshima T; Yang Y; Nakagawa M
Blood; 2024 Apr; 143(14):1379-1390. PubMed ID: 38142436
[TBL] [Abstract][Full Text] [Related]
3. TGF-β regulated leukemia cell susceptibility against NK targeting through the down-regulation of the CD48 expression.
Huang CH; Liao YJ; Chiou TJ; Huang HT; Lin YH; Twu YC
Immunobiology; 2019 Sep; 224(5):649-658. PubMed ID: 31421859
[TBL] [Abstract][Full Text] [Related]
4. CD48-expressing non-small-cell lung cancer cells are susceptible to natural killer cell-mediated cytotoxicity.
Park EJ; Jun HW; Na IH; Lee HK; Yun J; Kim HS; Kim Y; Hong JT; Han SB
Arch Pharm Res; 2022 Jan; 45(1):1-10. PubMed ID: 34905179
[TBL] [Abstract][Full Text] [Related]
5. Subversion of natural killer cell responses by a cytomegalovirus-encoded soluble CD48 decoy receptor.
Martínez-Vicente P; Farré D; Sánchez C; Alcamí A; Engel P; Angulo A
PLoS Pathog; 2019 Apr; 15(4):e1007658. PubMed ID: 30947296
[TBL] [Abstract][Full Text] [Related]
6. Acute myeloid leukemia immune escape by epigenetic CD48 silencing.
Wang Z; Xiao Y; Guan W; Wang M; Chen J; Zhang L; Li Y; Xiong Q; Wang H; Wang M; Li Y; Lv N; Li Y; Wang L; Yu L
Clin Sci (Lond); 2020 Jan; 134(2):261-271. PubMed ID: 31922199
[TBL] [Abstract][Full Text] [Related]
7. A CRISPR activation screen identifies MUC-21 as critical for resistance to NK and T cell-mediated cytotoxicity.
Lee DH; Ahn H; Sim HI; Choi E; Choi S; Jo Y; Yun B; Song HK; Oh SJ; Denda-Nagai K; Park CS; Irimura T; Park Y; Jin HS
J Exp Clin Cancer Res; 2023 Oct; 42(1):272. PubMed ID: 37858248
[TBL] [Abstract][Full Text] [Related]
8. Homotypic cell to cell cross-talk among human natural killer cells reveals differential and overlapping roles of 2B4 and CD2.
Kim EO; Kim TJ; Kim N; Kim ST; Kumar V; Lee KM
J Biol Chem; 2010 Dec; 285(53):41755-64. PubMed ID: 20813844
[TBL] [Abstract][Full Text] [Related]
9. Requirement of homotypic NK-cell interactions through 2B4(CD244)/CD48 in the generation of NK effector functions.
Lee KM; Forman JP; McNerney ME; Stepp S; Kuppireddi S; Guzior D; Latchman YE; Sayegh MH; Yagita H; Park CK; Oh SB; Wülfing C; Schatzle J; Mathew PA; Sharpe AH; Kumar V
Blood; 2006 Apr; 107(8):3181-8. PubMed ID: 15905190
[TBL] [Abstract][Full Text] [Related]
10. Cutting edge: the NK cell receptor 2B4 augments antigen-specific T cell cytotoxicity through CD48 ligation on neighboring T cells.
Lee KM; Bhawan S; Majima T; Wei H; Nishimura MI; Yagita H; Kumar V
J Immunol; 2003 May; 170(10):4881-5. PubMed ID: 12734329
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory 2B4 contributes to NK cell education and immunological derangements in XLP1 patients.
Meazza R; Falco M; Marcenaro S; Loiacono F; Canevali P; Bellora F; Tuberosa C; Locatelli F; Micalizzi C; Moretta A; Mingari MC; Moretta L; Aricò M; Bottino C; Pende D
Eur J Immunol; 2017 Jun; 47(6):1051-1061. PubMed ID: 28386908
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive genomic analysis identifying heterogeneity in peripheral T-cell lymphoma.
Yoshida N; Yamada K; Ohshima K
Cancer Sci; 2021 Apr; 112(4):1339-1347. PubMed ID: 33576080
[TBL] [Abstract][Full Text] [Related]
13. CD48 stimulation by 2B4 (CD244)-expressing targets activates human NK cells.
Messmer B; Eissmann P; Stark S; Watzl C
J Immunol; 2006 Apr; 176(8):4646-50. PubMed ID: 16585556
[TBL] [Abstract][Full Text] [Related]
14. Modulation of natural killer cell functions by interactions between 2B4 and CD48 in cis and in trans.
Claus M; Wingert S; Watzl C
Open Biol; 2016 May; 6(5):. PubMed ID: 27249817
[TBL] [Abstract][Full Text] [Related]
15. Genome-wide CRISPR screen identifies CDK6 as a therapeutic target in adult T-cell leukemia/lymphoma.
Ishio T; Kumar S; Shimono J; Daenthanasanmak A; Dubois S; Lin Y; Bryant B; Petrus MN; Bachy E; Huang DW; Yang Y; Green PL; Hasegawa H; Maeda M; Goto H; Endo T; Yokota T; Hatanaka KC; Hatanaka Y; Tanaka S; Matsuno Y; Yang Y; Hashino S; Teshima T; Waldmann TA; Staudt LM; Nakagawa M
Blood; 2022 Mar; 139(10):1541-1556. PubMed ID: 34818414
[TBL] [Abstract][Full Text] [Related]
16. High Expression of Intestinal Homing Receptor CD103 in Adult T-Cell Leukemia/Lymphoma, Similar to 2 Other CD8+ T-Cell Lymphomas.
Ishibashi H; Nimura S; Ishitsuka K; Mihashi Y; Mizoguchi M; Nakamura S; Okamura S; Momosaki S; Aoyagi K; Sakisaka S; Takeshita M
Am J Surg Pathol; 2016 Apr; 40(4):462-70. PubMed ID: 26813744
[TBL] [Abstract][Full Text] [Related]
17. Expression of activating natural killer-cell receptors is a hallmark of the innate-like T-cell neoplasm in peripheral T-cell lymphomas.
Uemura Y; Isobe Y; Uchida A; Asano J; Nishio Y; Sakai H; Hoshikawa M; Takagi M; Nakamura N; Miura I
Cancer Sci; 2018 Apr; 109(4):1254-1262. PubMed ID: 29363227
[TBL] [Abstract][Full Text] [Related]
18. Molecular Pathology of Adult T-Cell Leukemia/Lymphoma.
Ohshima K
Oncology; 2015; 89 Suppl 1():7-15. PubMed ID: 26550829
[TBL] [Abstract][Full Text] [Related]
19. Divergent Traits and Ligand-Binding Properties of the Cytomegalovirus CD48 Gene Family.
Martínez-Vicente P; Farré D; Engel P; Angulo A
Viruses; 2020 Jul; 12(8):. PubMed ID: 32731344
[TBL] [Abstract][Full Text] [Related]
20. Adult T-cell leukemia/lymphoma in Jujuy, north-west Argentina.
Marin O; Hasui K; Remondegui C; Sato E; Aye MM; Takenouchi N; Izumo S; Tajima K
Pathol Int; 2002; 52(5-6):348-57. PubMed ID: 12100517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
